Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash Flows from Operating Activities
Net earnings (loss)	$ 128,168	$ (111,739)
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:
Depreciation	188,034	199,693
Amortization	230,741	216,420
Share-based compensation expense	116,649	97,752
Amortization of debt issuance costs	15,661	13,256
Non-cash restructuring charges	43,002	4,858
Loss on disposal of property, plant and equipment	112	262
Unrealized losses (gains) on foreign currency remeasurements and transactions	6,841	(3,852)
Loss (earnings) from equity investments	(626)	523
Deferred income taxes	(88,101)	(140,727)
Increase (decrease) in cash from changes in (net of effect of acquisitions):
Accounts receivable	(166,115)	(52,388)
Inventories	(97,301)	(21,256)
Accounts payable	128,263	161,366
Contract liabilities	4,619	(39,103)
Income taxes	(2,174)	36,960
Accrued compensation and benefits	29,874	1,835
Other operating net assets (liabilities)	(34,331)	19,544
Net cash provided by operating activities	503,316	383,404
Cash Flows from Investing Activities
Additions to property, plant & equipment	(309,486)	(246,909)
Proceeds from the sale of business	27,000	0
Other investing activities	(1,038)	(2,114)
Net cash used in investing activities	(283,524)	(249,023)
Cash Flows from Financing Activities
Sale of shares to noncontrolling interests	0	1,000,000
Proceeds from borrowings of revolving credit facilities	35,862	18,966
Payments on existing debt	(386,006)	(165,094)
Payments on borrowings under revolving credit facilities	(34,148)	(18,642)
Equity issuance costs	0	(31,840)
Proceeds from exercises of stock options and purchases of stock under employee stock purchase plan	47,462	36,097
Payments in satisfaction of employees' minimum tax obligations	(48,939)	(18,823)
Other financing activities	(719)	(755)
Net cash provided by (used in) financing activities	(386,488)	819,909
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	3,040	603
Net increase (decrease) in cash, cash equivalents, and restricted cash	(163,656)	954,893
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period	1,789,686	837,566
Cash, Cash Equivalents, and Restricted Cash at End of Period	1,626,030	1,792,459
Supplemental Information
Cash paid for interest	187,799	224,656
Cash paid for income taxes	107,784	53,803
Additions to property, plant & equipment included in accounts payable	77,751	66,040
Non-Cash Investing and Financing Activities
Conversion of Series A preferred stock to common stock	0	445,319
Reconciliation of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Cash and cash equivalents	890,258	898,578
Restricted cash, current	19,064	183,611
Restricted cash, non-current	716,708	710,270
Total cash, cash equivalents, and restricted cash shown in the Condensed Consolidated Statements of Cash Flows	$ 1,626,030	$ 1,792,459